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The primary structure of insulin from the Holocephalan fish, Hydrolagus colliei (the ratfish), has been estab- 
lished by automated Edman degradation as: 
5 10 15 20 
Achain:GIVEQCCHNTCSLANLEGY CN 
5 10 15 20 25 30 
Bchain:VPTQRLCGS HLVDALYFVCGERGFFYSPKPI*REL 
The presence of a COOH-terminal extension to the B-chain is consistent with the occurrence of a single 
base mutation in the region of the gene encoding one of the dibasic residue processing sites 
[Arg31(AGA) -Ile*(AUA)] with the result hat the ratfish as utilised an alternative cleavage site within 
the C-peptide region of proinsulin. 
(Ratjish pancreas) Holocephalan 
1. INTRODUCTION 
In all species studied so far, proinsulin is con- 
verted to insulin and the C-peptide of proinsulin by 
specific proteolytic cleavages at sites of pairs of 
basic amino acid residues [l]. The enzyme system 
responsible for effecting these cleavages in 
eukaryotes has yet to be characterized fully but it 
has been postulated that cleavage by a trypsin-like 
enzyme is followed by removal of the basic amino 
acid residues by an enzyme with carboxypeptidase 
B-like specificity [2]. The Holocephalan fishes, 
represented by three extant families: Hydrolagus 
(ratfishes), Chimaera (rabbit fishes) and 
Caflorhynchus (elephant fishes), were the first 
class of vertebrate in evolution to develop a pan- 
creatic gland with both exocrine and endocrine 
parenchyma [3]. The Holocephalan fishes are 
phylogenetically related to the Elasmobranchian 
Insulin C-peptide HPLC 
fishes but diverged from the line of evolution 
leading to contemporary sharks and rays at least 
250 million years ago. Although the primary struc- 
tures of insulins from several Teleostean fishes 
have been determined (review [4]), structural infor- 
mation regarding Elasmobranchian insulins is con- 
fined to that of the ray, Torpedo marmorata [5] 
and an incomplete sequence of insulin from the 
spiny dogfish, Squalus ancanthias [6]. This study 
demonstrates that the ratfish employes a hitherto 
undescribed pathway of posttranslation pro- 
teolysis in conversion of proinsulin to insulin. 
2. MATERIALS AND METHODS 
2.1. Tissue extraction 
Ratfish were collected at Bamfield Marine Sta- 
tion, Vancouver Island, Canada. Pancreata 
(203 g) from approx. 600 ratfishes were extracted 
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with 8 vols ethanol/O.7 M HCl (3 : 1, v/v) using a 
Waring blender. The homogenate was stirred at 
4°C for 5 h, centrifuged (1600 x g, 1 h) and 
ethanol removed from the supernatant under 
reduced pressure. After further centrifugation 
(20000 x g, 1 h), peptides were isolated from the 
supernatant using Sep-Pak Cl8 cartridges (Waters 
Associates) [7]. Bound material was eluted with 
acetonitrile/water/trifluoroacetic acid (70 : 29 : 1) 
and the effluent lyophilized. 
2.2. Purification of insulin 
The pancreatic extract, after Sep-Pak concentra- 
tion, was redissolved in 1% (v/v) trifluoroacetic 
acid (2 ml) and chromatographed on a column 
(90 x 1.6 cm) of Sephadex G-50 fine (Pharmacia) 
equilibrated with 0.1 M ammonium acetate solu- 
tion, pH 6.8. The column was eluted at 4°C and at 
a flow rate of 10 ml/h. Fractions (2.1 ml) with K,, 
between 0.27 and 0.44 (Ka, of porcine insulin = 
0.36) were purified further by reverse-phase 
HPLC. Samples (1 ml) were injected onto a Vydac 
218 TP column (0.46 x 2.5 cm) eluted at 30°C and 
at a flow rate of 1.5 ml/min with a linear gradient 
(total volume 45 ml) formed from acetonitrile/wa- 
ter/trifluoroacetic acid (21 .O : 78.9 : 0.1) and aceto- 
nitrile/water/trifluoroacetic acid (35.0 : 64.9 : 0.1). 
UV absorbance was measured at 214 and 280 nm. 
Ratfish insulin was purified to homogeneity on 
a Supelcosil LC-3DP phenyl column (0.46 x 
25 cm) equilibrated with 0.1% (v/v) trifluoroacetic 
acid at 30°C and a flow rate of 1.5 ml/min. The 
concentration of acetonitrile in the eluting solvent 
was increased to 17.5% (v/v) over 5 min followed 
by an increase to 35% (v/v) over 25 min. Ratfish 
insulin (10 nmol) was reduced and pyridylethyl- 
ated according to [B] and the derivatized A- and B- 
chains were separated by reverse-phase HPLC 
under the conditions shown in fig.2. 
2.3. Structural analysis 
Amino acid compositions of the A- and B-chains 
were determined using 2 nmol peptide as described 
[9]. The primary structures of the peptides were 
determined using approx. 10 nmol A-chain and 
6 nmol B-chain by automated Edman degradation 
using an Applied Biosystems model 470A gas- 
phase sequencer [lo]. The detection limit for PTH- 
amino acids was 0.5 pmol. 
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3. RESULTS 
3.1. Purification of insulin 
Extracts of ratfish pancreas contained only trace 
amounts of insulin-like immunoreactivity when 
measured in a radioimmunoassay using an an- 
tiserum to porcine insulin indicating that ratfish in- 
sulin probably adopts an appreciably different 
conformation to the mammalian peptide. After 
concentration on Sep-Pak cartridges, the pan- 
creatic extracts were chromatographed on a 
Sephadex G-50 gel filtration column (fig.1). The 
fractions indicated by the hatched bar were in- 
dividually injected onto a Cl8 reverse-phase 
HPLC column and a representative lution profile 
is shown in fig.2. The peak designated by the star 
was eluted from the column with a retention time 
comparable to that of porcine insulin and showed 
a similar ratio of UV absorbance measured at 214 
and 280 nm [l 11. Ratfish insulin was separated 
from an uncharacterized impurity by reverse-phase 
HPLC on a diphenylmethylsilylsilica column 
(fig.3). 
3.2. Structural analysis 
The amino acid compositions of purified ratfish 
insulin A- and B-chains are shown in table 1 and 
the results of automated Edman degradation of the 
peptides in table 2. The average repetitive yields 
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Fig. 1. Elution profile on Sephadex G-50 of an extract of 
ratfish pancreas after partial purification using Sep-Pak 
Cl8 cartridges. V0 and vt refer to the void volume and 
total volume of the column and Z denotes the elution 
volume of human insulin. The fractions indicated by the 
hatched bar were further purified. 
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Fig.2. Reverse-phase HPLC on a Supelcosil LC-18-DB 
column of ratfish insulin after partial purification by gel 
permeation chromatography. The star denotes the 
insulin peak and (- - -) the concentration of acetonitrile 
in the eluting solvent. The arrow denotes the retention 
time of human insulin. 
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Fig.3. Purification to homogeneity of ratfish insulin 
(denoted by the asterisk) on a Supelcosil LC-3DP 
column. The arrow indicates the retention time of 
human insulin and (- - -) the concentration of 
acetonitrile in the eluting solvent. 
Table ,l 
Amino acid compositions of A-chain and B-chain of 
insulin from the ratfish 
Residue Relative amount 
A-chain B-chain 
Asx 2.90 (3) 1.19 (1) 
Thr 0.83 (1) 0.91 (1) 
Ser 1.07 (1) 2.08 (2) 
Glx 2.91 (3) 4.06 (3) 
Pro - (0) 4.19 (3) 
ClY 2.00 (2) 3.00 (3) 
Ala 0.91 (1) 0.96 (1) 
Val 0.46 (1) 2.73 (3) 
Met - (0) - (0) 
Be 0.45 (1) 0.75 (1) 
Leu 1.79 (2) 5.00 (4) 
Tyr 0.89 (1) 1.80 (2) 
Phe - (0) 2.63 (3) 
His 0.89 (1) 1.01 (1) 
Lys - (0) 1.23 (1) 
Arg - (0) 3.05 (3) 
Data are expressed relative to glycine. Numbers in 
parentheses represent the values from the sequence 
determinations 
were A-chain (93.1%) and B-chain (90.0%). 
Unambiguous assignation of 21 amino acid 
residues of the A-chain and 34 residues of the B- 
chain was possible. Agreement between the amino 
acid composition of the A-chain and the proposed 
sequence was good indicating that the full se- 
quence had been obtained. The low values for the 
relative amount of Ile and Val are to be expected 
from the known resistance of the sterically 
hindered Ile-Val bond to acid hydrolysis. The 
amino acid composition of the B-chain, however, 
suggested that a total of 37 amino acids may be 
present with the possibility of additional Glx, Pro 
and Leu residues in the molecule. 38 cycles of 
automated Edman degradation were carried out 
and no trace of any PTH-amino acid derivative 
was observed beyond cycle 34. Nevertheless, it is 
possible that the tripeptide [Glx Pro Leu] may have 
been washed out of the glass fibre disc of the se- 
quencer at cycle 35 so that further structural 
studies are required for an unambiguous 
demonstration that the B-chain of ratfish insulin is 
not extended beyond Leu 34. The primary struc- 
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Table 2 
Automated Edman degradation of the A-chain and B- 
chain of insulin from the ratfish 
Cycle A-chain B-chain 
no. 
PTH- Yield PTH- Yield 
amino tpmol) amino (pm011 
acid acid 
1 
2 
3 
4 
5 
6 
7 
8 
9 
10 
11 
12 
13 
14 
15 
16 
17 
18 
19 
20 
21 
22 
23 
24 
25 
26 
27 
28 
29 
30 
31 
32 
33 
34 
GUY 
Ile 
Val 
Glu 
Gln 
PE-Cys 
PE-Cys 
His 
Asn 
Thr 
PE-Cys 
Ser 
Leu 
Ala 
Asn 
Leu 
Glu 
Gly 
Tyr 
PE-Cys 
Asn 
7423 Val 
8577 Pro 
7688 Thr 
3874 Gln 
6009 Arg 
3633 
3994 
1385 
4375 
2166 
2406 
1614 
2764 
2547 
2696 
2650 
1435 
2005 
1791 
1293 
903 
Leu 
PE-Cys 
Gly 
Ser 
His 
Leu 
Val 
Asp 
Ala 
Leu 
Tyr 
Phe 
Val 
PE-Cys 
Gly 
Glu 
Arg 
Gly 
Phe 
Phe 
T yr 
Ser 
Pro 
Lys 
Pro 
Ile 
Arg 
Glu 
Leu 
5182 
3279 
2162 
5407 
1513 
4322 
2525 
3264 
1111 
1039 
2013 
2026 
823 
1481 
1718 
1282 
1589 
1503 
878 
1227 
534 
535 
698 
619 
770 
346 
89 
249 
114 
162 
127 
70 
53 
83 
PE-Cys, 4-vinylpyridine derivative of cysteine 
ture of ratfish insulin is compared with the insulin 
from an elasmobranchian fish, T. marmorata [5] 
and with human and guinea pig insulins in table 3. 
4. DISCUSSION 
The sequence of ratfish insulin shows strong 
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homology with that of the ray, T. marmorata [5] 
in both the A-chain (86%) and corresponding 
region of the B-chain (70%) (table 3). With the ex- 
ception of Ala for Phe (A14) and Glu for Pro 
(B21), the amino acid substitutions are consistent 
with single base changes in the corresponding se- 
quences of the DNAs. In common with all mam- 
malian insulins yet studied, except that of the 
coypu [12], the A-chain of ratfish insulin has 21 
amino acid residues. In contrast, insulin from the 
Elasmobranchian fish, S. acanthias (Spiny 
dogfish) has 22 residues [6]. Several substitutions 
in the proposed receptor-binding region of mam- 
malian insulins that are found in insulins from the 
torpedo and dogfish, e.g. His for Gln (AS), Pro 
for Glu (B21), Lys for Arg (B22) and Tyr for Phe 
(B25) are not found in ratfish insulin. The His 
residue at BlO, important in the formation of zinc- 
containing hexamers of insulin, that is lost in the 
insulin of the cyclostome, Myxine glutinosa 
(Atlantic hagfish) [13], is retained in ratfish in- 
sulin. The ratfish does, however, share with the 
hagfish the uncommon substitutions Asn at Al5 
and Thr at B3. The presence of an Ala residue at 
A14, a site that is also involved in the hexameriza- 
tion of insulin, and a Pro residue at B30 are struc- 
tural features that have not previously been 
observed in insulins from other species. 
As shown in table 3, the tetrapeptide xtension 
to the COOH-terminus of the B-chain of ratfish in- 
sulin (Ile Arg Glu Leu) is homologous to the N- 
terminal region of the C-peptide of proinsulin 
from the guinea pig (Arg Arg Glu Leu) and human 
(Arg Arg Glu Ala). The substitution by Ile in rat- 
fish insulin of Arg in mammalian insulin at B3 1 re- 
quires only a single base change in the 
corresponding region of the DNA (AUA for 
AGA). It is proposed, therefore, that the increased 
length of the ratfish insulin B-chain is a conse- 
quence of a mutation in ratfish proinsulin at the 
processing site linking the B-chain to the C- 
peptide. An alternative processing then occurs 
within the C-peptide region of proinsulin. This 
cleavage is probably not effected by the trypsin- 
like enzyme normally responsible for the proin- 
sulin processing between the B-chain and the C- 
peptide. Tager et al. [14] have provided evidence 
for a chymotrypsin-like enzyme participating in 
normal proinsulin processing in the rat by a selec- 
tive cleavage of the Gln 22-Thr 23 peptide bond of 
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Table 3 
A comparison of the sequence of ratfish insulin with insulins from the guinea pig, human and an elasmobranchian fish, Torpedo m~rmoruru 
A-chain 
5 10 15 20 
Ratfish Gly iie Val GluGlnCysCys HisAsnThrCys Ser Leu AlaAsnLeuGluGly TyrCysAsn 
Guinea pig - - - Asp - - - ThrGly - - ThrArg HisGIn - Gin Ser - - - 
Human - - - - - - - Thr Ser Ile - - - TyrGln - - Asn - - - 
‘&r&o _ - - - His _ _ - - _ - - _ PheAsp _ _ _ 
B-chain 
5 10 1s 20 25 30 
Ratfish Val ProThrGtnArgI.cuI > r<rly Ser 
Arg His - - - - Asn - - GluThr Glu 
Human PheValAsn - His - - - - - - - Glu - - - Leu - - - - - - - - - Thr - - Thflrg - - AlaGlu 
Torpedo Leu-Ser-His- - - - - - -Clu- - - - - - -ProLys- -Tyr-Leu- -Ala 
The boxed residues are the dibasic processing site followed by the N-terminal part of the C-peptide of proinsulin 
the C-peptide. A further chymotryptic cleavage 
has also been found to occur between Leu 24 and 
Ala 25 of the C-peptide [15]. 
Although processing at monobasic Arg residues 
is common in prohormone processing (review 
[16]), the enzyme system in the ratfish &cell seems 
unable to process at the single Arg B32 residue. 
The failure of the enzyme system in the human 
pancreatic P-cell to process at a monobasic residue 
has been described for patients with hyperproin- 
sulinemia [17]. In this case, a mutation had oc- 
curred in the gene segment encoding the Lys-Arg 
processing site between the C-peptide and the A- 
chain, resulting in a Lys-X sequence which could 
not be processed and which led to glucose in- 
tolerance in the patients. The deleterious metabolic 
effects arising from the inability of the organism to 
process proinsulin to insulin have been overcome 
in the ratfish by utilising an alternative chymotryp- 
tic cleavage site within the C-peptide region of pro- 
insulin. A recent structure-function study [ 181 
using analogues of porcine insulin modified at the 
COOH-terminus of the B-chain has demonstrated 
that the Phe residue at B25 is of critical importance 
in the interaction of insulin with its receptor. This 
interaction is, however, influenced by steric hin- 
drance involving the COOH-terminal domain of 
the B-chain. Thus, the presence of the COOH- 
terminal extension to the B-chain of ratfish insulin 
is expected to modify, at least to some extent, the 
bioactivity of the molecule. Confirmation of this 
hypothesis is underway. 
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